LAURA LANDGRAF: Open Payments
NPI 1679779227 · BANNOCKBURN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 36 payments from 12 companies in 2025. Trend: 2023 $481 · 2024 $786 · 2025 $886
Food & beverage: $886
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $244 |
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Actelion Pharmaceuticals US, Inc. | 1 | $100 |
| Boston Scientific Corporation | 3 | $73 |
| Alnylam Pharmaceuticals Inc. | 2 | $57 |
| BridgeBio Pharma, Inc. | 2 | $37 |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $34 |
| PFIZER INC. | 1 | $33 |
| Abbott Laboratories | 1 | $22 |
Products named: Wegovy, LEQVIO, UPTRAVI, FARXIGA, WATCHMAN FLX, ONPATTRO, WAINUA, Attruby.
Industry payments across IL — which companies pay providers there.
